PacBio (PACB) announced an expanded partnership with seqWell. Under the new agreement, PacBio will distribute seqWell’s LongPlex Multiplexing Kit, a scalable, easy-to-use sample preparation solution designed for use with PacBio HiFi sequencing and optimized for efficient transposase-based DNA fragmentation and multiplexing. LongPlex removes sample prep bottlenecks, enabling researchers to produce high-quality libraries quickly, support current studies cost-efficiently, and power the next wave of population-scale research. This collaboration expands the portfolio of workflow options available to PacBio customers, complementing PacBio’s highly accurate long-long read technology with an additional flexible, high-throughput sample prep solution. The LongPlex Multiplexing Kit uses tagmentation to simultaneously fragment and index DNA for up to hundreds of samples in a single run, making it ideal for large-scale screening and targeted resequencing efforts.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- PacBio announces entry into high-throughput carrier screening market
- PacBio, EpiCypher partner to deliver new insights into epigenomics
- Cathie Wood Pours Over $46M into Biotech Stocks, 8/19/2025
- Pacific Biosciences’ Earnings Call Highlights Growth and Challenges
- PacBio price target raised to $1.50 from $1.25 at Piper Sandler